StageZero Life Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep '23 Sep 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Revenue	2.88	3.8	5.07	4.15	0.14	0.19
Revenue Growth (YoY)	-37.63%	-25.12%	22.07%	2893.29%	-25.38%	-54.85%
Cost of Revenue	2.85	4.2	3.89	3.46	1.1	1.09
Gross Profit	0.03	-0.4	1.18	0.7	-0.96	-0.91
Selling, General & Admin	4.48	6.99	8.37	4.21	3.93	3.76
Research & Development	0.1	0.35	0.77	0.22	-	-
Operating Expenses	4.58	7.34	9.14	4.43	3.99	3.76
Operating Income	-4.55	-7.75	-7.96	-3.74	-4.95	-4.67
Interest Expense	-0.39	-0.28	-0.2	-0.66	-0.75	-0.47
Currency Exchange Gain (Loss)	-	-	-	-	-0.19	-
Other Non Operating Income (Expenses)	-0.18	2.18	2.58	-1.4	2.41	1.45
EBT Excluding Unusual Items	-5.12	-5.85	-5.59	-5.8	-3.48	-3.69
Merger & Restructuring Charges	-	-	-1.24	-	-	-
Impairment of Goodwill	-7.36	-7.36	-	-	-	-
Other Unusual Items	-0.05	1.8	-0.66	-1.07	-	-
Pretax Income	-12.53	-11.42	-7.48	-6.86	-3.48	-3.69
Net Income	-12.53	-11.42	-7.48	-6.86	-3.48	-3.69
Net Income to Common	-12.53	-11.42	-7.48	-6.86	-3.48	-3.69
Shares Outstanding (Basic)	103	99	71	45	26	17
Shares Outstanding (Diluted)	103	99	71	45	26	17
Shares Change (YoY)	32.99%	40.60%	57.77%	69.14%	54.89%	41.63%
EPS (Basic)	-0.12	-0.11	-0.11	-0.15	-0.13	-0.22
EPS (Diluted)	-0.12	-0.11	-0.11	-0.15	-0.13	-0.22
Free Cash Flow	-0.81	-3.53	-9.1	-3.14	-4.64	-3.46
Free Cash Flow Per Share	-0.01	-0.04	-0.13	-0.07	-0.17	-0.20
Gross Margin	1.04%	-10.64%	23.23%	16.75%	-	-
Operating Margin	-157.83%	-204.13%	-157.12%	-90.00%	-3567.44%	-2510.83%
Profit Margin	-434.85%	-300.79%	-147.67%	-165.32%	-2510.24%	-1986.66%
Free Cash Flow Margin	-28.07%	-92.98%	-179.61%	-75.55%	-3341.82%	-1863.54%
EBITDA	-4.46	-7.51	-7.65	-3.48	-4.69	-4.06
EBITDA Margin	-154.88%	-197.81%	-150.98%	-83.86%	-	-
D&A For EBITDA	0.09	0.24	0.31	0.26	0.26	0.61
EBIT	-4.55	-7.75	-7.96	-3.74	-4.95	-4.67
EBIT Margin	-157.83%	-204.13%	-157.12%	-90.00%	-	-
Revenue as Reported	-	-	-	-	-	0.19

Updated Dec 16, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.